Semaglutide Reduced Inflammatory Biomarkers in HIV Patients With Lipohypertrophy

(MedPage Today) -- DENVER -- People with HIV who received semaglutide (Ozempic, Wegovy) had reduced levels of several inflammatory biomarkers associated with cardiovascular disease, a randomized controlled trial showed. After 32 weeks, interleukin...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news